Updating our Aggressive stocks: NCR, Diebold Nixdorf & Idexx Laboratories

Article Excerpt

NCR CORP. $31 (www.ncr.com) is still a buy. The company makes automated teller machines (ATMs), cash registers, self-serve checkouts and kiosks for theatres and arenas. The stock jumped 10% on media reports that private-equity firm Veritas Capital is preparing to launch a takeover bid. Even if an offer fails to materialize, NCR should continue to benefit from its plan to expand its software and services businesses. In the first quarter of 2022, services accounted for 72% of its revenue. That cuts its reliance on new hardware sales. NCR is a buy. DIEBOLD NIXDORF INC. $3.39 (www.dieboldnixdorf.com) is still a hold. The world’s biggest maker of automated teller machines (ATMs). recently suspended shipments and sales to clients in Russia. Supply chain disruptions are also slowing its deliveries. As a result, Diebold now expects its revenue for 2022 will total $3.8 billion, down from its earlier forecast of $4.1 billion. Diebold is a hold. IDEXX LABORATORIES INC. $386 (www.idexx.com) is still a hold. The company makes equipment that veterinarians use to detect diseases in pets…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.